billion in annual sales in 2016, 73% in U.S., annual revenue has grown for 37 straight years
CAGR (compound annual growth rate) in sales over 37 years
employees globally in 2016
manufacturing and research and development locations worldwide
included in the Standard & Poor’s 500 Index
on Fortune Magazine’s “FORTUNE 500” list for 2017
on Fortune Magazine’s “World’s Most Admired Companies” list for the “Medical Equipment” industry for 2017
on Fortune Magazine’s “100 Best Companies to Work For” list (U.S.) for 2017
spent on research and development in 2016, consistently spend between 5.0 – 6.3% of sales on research and development annually since 2000
patents owned globally in 2016
initial public offering of stock
listed on the New York Stock Exchange under this ticker
2825 Airview Boulevard, Kalamazoo, MI 49002 U.S.A.
SYK CORP 2017-10-45 Rev. 1